Contact us in British Columbia and Yukon


Crohn’s and colitis are much more manageable when we share our experiences with each other. Education events, chapter meetings, and fundraising activities are great opportunities to meet people who are living with IBD, their families and friends, and to learn of local resources and health professionals to support you and your family.

Leadership Giving Officer, Western Canada
Susan Hampton

604-314-1151

Coordinator, Development and Community Engagement, BC/Yukon/SK
Mishal Tahir

778-879-3473
1-800-513-8202

Coordinator, Development & Community Engagement, Southwest BC
Mishal Tahir

778-879-3473
1-800-513-8202

Gutsy Learning Sereies logo on background of a public speaker

Navigating Crohn's and colitis in the Workplace: Empowering Tools for Disclosure and Accommodations

The Gutsy Learning Series (GLS) offers a unique opportunity to learn directly from Canada’s leading experts in inflammatory bowel disease (IBD). Whether you're living with Crohn’s ...

 • 
Virtual
 • 
A family gathered around a child looking at a tablet

Ask the Expert: Caregiving and IBD

Are you supporting someone with inflammatory bowel disease (IBD), or living with IBD while providing care to someone else? You're not alone.  Join our free Ask the Expert event designed to ...

 • 
Virtual - Online
 • 
Remember to bookmark this page.

British Columbia & Yukon Office

2110-439 University Avenue
Toronto, ON M5G 1Y8

bc@crohnsandcolitis.ca 416-920-5035 or 1-800-387-1479

Search by Postal Code

News

The Canadian Inflammatory Bowel Disease Research Consortium awards first $1M Pioneer Grant from Takeda Canada

The Canadian Inflammatory Bowel Disease Research Consortium awards first $1M Pioneer Grant from Takeda Canada

Crohn’s and Colitis Canada and Pfizer Canada Announce 2022 Women in IBD Award Recipients

Crohn’s and Colitis Canada and Pfizer Canada Announce 2022 Women in IBD Award Recipients

Health Canada has approved SKYRIZI® (risankizumab) an intravenous and subcutaneous medication treatment for adults with moderately to severely active Crohn's Disease

Health Canada has approved SKYRIZI® (risankizumab) an intravenous and subcutaneous medication treatment for adults with moderately to severely active Crohn's Disease

Send an eCard to Friends or Family Members in Support of Crohn's and Colitis Canada

Send an eCard to Friends or Family Members in Support of Crohn's and Colitis Canada

 18 19 20 21 22 23 24 25 26 27